Klaipėdos biokuras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,140,107 | 1,082,183 | 1,493,101 | 2,992,108 | 3,218,533 | 1,357,435 | 1,022,179 | 646,930 |
| Profit before tax | -285,222 | -378,760 | -386,754 | 247,831 | 1,045,478 | 1,005,298 | 962,184 | 382,933 |
| Net profit | -397,862 | -477,364 | -484,177 | 132,947 | 888,752 | 854,614 | 820,031 | 364,841 |
| Equity | 3,306,324 | 1,928,960 | 894,783 | 477,730 | 1,366,482 | 721,096 | 941,127 | 1,411,968 |
| Liabilities | 1,520,775 | 1,087,748 | 911,153 | 350,116 | 156,896 | 15,280 | 1,122 | 5,030 |
| Non-current assets | 4,168,051 | 2,670,611 | 906,724 | 32,058 | 32,058 | 32,058 | 32,058 | 1,032,058 |
| Current assets | 618,761 | 315,602 | 869,572 | 714,092 | 1,433,154 | 672,825 | 878,698 | 384,940 |
| Total assets | 4,786,812 | 2,986,213 | 1,776,296 | 746,150 | 1,465,212 | 704,883 | 910,756 | 1,416,998 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 405,606 | 378,628 | 106,263 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +14.7% | -5.1% | +38.0% | +100.4% | +7.6% | -57.8% | -24.7% | -36.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -8.3% | -16.0% | -27.3% | 17.8% | 60.7% | 121.2% | 90.0% | 25.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -12.0% | -24.7% | -54.1% | 27.8% | 65.0% | 118.5% | 87.1% | 25.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -34.9% | -44.1% | -32.4% | 4.4% | 27.6% | 63.0% | 80.2% | 56.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -25.0% | -35.0% | -25.9% | 8.3% | 32.5% | 74.1% | 94.1% | 59.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.6 | 1.0 | 0.7 | 0.1 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,140,107 | 1,082,183 | 1,493,101 | 2,992,108 | 3,218,533 | 1,357,435 | 1,022,179 | 646,930 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Klaipėdos biokuras - Social security debts
The company had no debts to Sodra
Klaipėdos biokuras - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Klaipedos biokuras, UAB (code 302301254) is a Private Limited Liability Company operating in the production of electricity from renewable sources. In 2025, the company reported revenue of €646.9K and net profit of €364.8K, corresponding to a profit margin of 56.4%. Revenue declined by 36.7% year on year and by 52.3% over two years, moving from €1.36M in 2023 to €1.02M in 2024 and then to the latest level in 2025. Despite the lower turnover, profitability remained solid, with net profit easing from €854.6K in 2023 to €820.0K in 2024 and €364.8K in 2025. The balance sheet strengthened further: total assets increased to €1.42M, equity reached €1.41M, and liabilities were only €5.0K, indicating a very high equity ratio of 99.7%. Long-term assets rose to €1.03M in 2025 from €32.1K in both previous years, while short-term assets were €384.9K. Asset turnover was 0.46x, and revenue per employee was €646.9K.